Heterogeneity of Monoclonal Antibodies(14)

monoclonal antibody by LC/MS/MS.Anal Chem 77:1432–1439.

45.Zhu L,van de Lavoir MC,Albanese J,Beenhouwer

DO,Cardarelli PM,Cuison S,Deng DF,Desh-pande S,Diamond JH,Green L,Halk EL,Heyer BS,Kay RM,Kerchner A,Leighton PA,Mather CM,Morrison SL,Nikolov ZL,Passmore DB,Pra-das-Monne A,Preston BT,Rangan VS,Shi M, Srinivasan M,White SG,Winters-Digiacinto P, Wong S,Zhou W,Etches RJ.2005.Production of human monoclonal antibody in eggs of chimeric chickens.Nat Biotechnol23:1159–1169.(Epub 2005Aug1128.)

46.Beck A,Bussat MC,Zorn N,Robillard V,Klinguer-

Hamour C,Chenu S,Goetsch L,Corvaia N,Van Dorsselaer A,Haeuw JF.2005.Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1receptor antibodies produced in CHO and NS0cells.

J Chromatogr B Analyt Technol Biomed Life Sci 819:203–218.

47.Lyubarskaya Y,Houde D,Woodard J,Murphy D,

Mhatre R.2006.Analysis of recombinant mono-clonal antibody isoforms by electrospray ionization mass spectrometry as a strategy for streamlining characterization of recombinant monoclonal anti-body charge heterogeneity.Anal Biochem348:24–39(Epub2005Oct2025.)

48.Johnson KA,Paisley-Flango K,Tangarone BS,

Porter TJ,Rouse JC.2007.Cation exchange-HPLC and mass spectrometry reveal C-terminal amidation of an IgG1heavy chain.Anal Biochem 360:75–83(Epub2006Oct2030.)

49.Notani GW,Munro AJ,Knopf PM.1966.A charge

difference between an intracellular and secreted mouse myeloma globulin.Biochem Biophys Res Commun25:395–401.

50.Wenisch E,Reiter S,Hinger S,Steindl F,Tauer C,

Jungbauer A,Katinger H,Righetti PG.1990.

Shifts of isoelectric points between cellular and secreted antibodies as revealed by isoelectric focusing and immobilized pH gradients.Electro-phoresis11:966–969.

51.Kroon DJ,Baldwin-Ferro A,Lalan P.1992.Iden-

tification of sites of degradation in a therapeutic monoclonal antibody by peptide mapping.Pharm Res9:1386–1393.

52.Chelius D,Rehder DS,Bondarenko PV.2005.

Identification and characterization of deamidation sites in the conserved regions of human immuno-globulin gamma antibodies.Anal Chem77:6004–6011.

ami A,Ohtsu A,Takahama S,Fujii T.1996.The

effect of pH,hydrogen peroxide and temperature on the stability of human monoclonal antibody.

J Pharm Biomed Anal14:1133–1140.

54.Dai HJ,Krull IS.1998.Thermal stability studies

of immunoglobulins using capillary isoelectric

focusing and capillary zone electrophoretic meth-ods.J Chromatogr A807:121–128.

55.Alexander AJ,Hughes DE.1995.Monitoring of

IgG antibody thermal stability by micellar electro-kinetic capillary chromatography and matrix-assisted laser desorption/ionization mass spectro-metry.Anal Chem67:3626–3632.

56.Andya JD,Maa YF,Costantino HR,Nguyen PA,

Dasovich N,Sweeney TD,Hsu CC,Shire SJ.1999.

The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody.Pharm Res16:350–358. 57.Rao PE,Kroon DJ.1993.Orthoclone OKT3.

Chemical mechanisms and functional effects of degradation of a therapeutic monoclonal antibody.

In:Wang YJ,Pearlman R,editors.Stability and characterization of protein and peptide drugs:Case histories.New York:Plenum Press.

135–158.

58.Wenisch E,Jungbauer A,Tauer C,Reiter M,

Gruber G,Steindl F,Katinger H.1989.Isolation of human monoclonal antibody isoproteins by pre-parative isoelectric focusing in immobilized pH gradients.J Biochem Biophys Methods18:309–322.

59.Bai L,Burman S,Gledhill L.2000.Development of

ion exchange chromatography methods for mono-clonal antibodies.J Pharm Biomed Anal22:605–611.

60.Cacia J,Keck R,Presta LG,Frenz J.1996.

Isomerization of an aspartic acid residue in the complementarity-determining regions of a recom-binant antibody to human IgE:Identification and effect on binding affinity.Biochemistry35:1897–1903.

61.Harris RJ.2005.Heterogeneity of recombinant

antibodies:Linking structure to function.Dev Biol (Basel)122:117–127.

62.Rehder DS,Dillon TM,Pipes GD,Bondarenko PV.

2006.Reversed-phase liquid chromatography/ mass spectrometry analysis of reduced monoclonal antibodies in pharmaceutics.J Chromatogr A 1102:164–175.(Epub2005Nov2017.)

63.Gadgil HS,Bondarenko PV,Pipes GD,Dillon TM,

Banks D,Abel J,Kleemann GR,Treuheit MJ.

2006.Identification of cysteinylation of a free cysteine in the Fab region of a recombinant mono-clonal IgG1antibody using Lys-C limited proteo-lysis coupled with LC/MS analysis.Anal Biochem 355:165–174.(Epub2006Jun2015.)

64.Tous GI,Wei Z,Feng J,Bilbulian S,Bowen S,

Smith J,Strouse R,McGeehan P,Casas-Finet J, Schenerman MA.2005.Characterization of a novel modification to monoclonal antibodies: Thioether cross-link of heavy and light chains.

Anal Chem77:2675–2682.

65.Angal S,King DJ,Bodmer MW,Turner A,Lawson

AD,Roberts G,Pedley B,Adair JR.1993.A single

DOI10.1002/jps JOURNAL OF PHARMACEUTICAL SCIENCES,VOL.97,NO.7,JULY2008

HETEROGENEITY OF MONOCLONAL ANTIBODIES2439